World's Best Scientists 2026 revealed!
Patrício Soares-da-Silva

Patrício Soares-da-Silva

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
15582
World Ranking
8670
National Ranking
33

Medicine

D-Index
70
Citations
17356
World Ranking
20103
National Ranking
18

Patrício Soares-da-Silva publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Patrício Soares-da-Silva sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 623 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Patrício Soares-da-Silva D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Patrício Soares-da-Silva sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 66 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Patrício Soares-da-Silva is affiliated with Bial in Portugal and has contributed extensively to the field of medicine, with a particular focus on neurology. Their work spans 175 publications concentrated mainly in neurology, psychiatry and mental health, pharmacology, cellular and molecular neuroscience, and molecular biology.

The scientist's research primarily addresses neurological disorders and treatments. Key topics in their body of work include Parkinson's disease mechanisms and treatments, neurological disorders and treatments, botulinum toxin and related neurological disorders, neuroscience and neuropharmacology research, epilepsy research and treatment, attention deficit hyperactivity disorder, and eicosanoids and hypertension pharmacology.

Frequent publication venues for this researcher include:

  • Journal of the Neurological Sciences
  • Parkinsonism & Related Disorders
  • Neurology
  • CHEST Journal
  • Translational Neurodegeneration

Notable recent papers are:

  • Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study, 2020, Translational Neurodegeneration
  • Redefining the strategy for the use of COMT inhibitors in Parkinson's disease: the role of opicapone, 2021, Expert Review of Neurotherapeutics
  • Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial, 2020, Epilepsy & Behavior
  • Liver says no: the ongoing search for safe catechol O-methyltransferase inhibitors to replace tolcapone, 2020, Drug Discovery Today
  • Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease, 2022, Movement Disorders

Frequent coauthors collaborating with Patrício Soares-da-Silva include:

  • José Rocha
  • Diogo Magalhães
  • Joaquim J. Ferreira
  • Andrew J. Lees
  • José-Francisco Rocha

Best Publications

  • Pharmacokinetic and safety profile of trans‐resveratrol in a rising multiple‐dose study in healthy volunteers

    Luis Almeida;Manuel Vaz-da-Silva;Amílcar Falcão;Eva Soares

  • Mechanisms of Action of Carbamazepine and Its Derivatives, Oxcarbazepine, BIA 2-093, and BIA 2-024*

    António F. Ambrósio;Patrício Soares-da-Silva;Caetana M. Carvalho;Arsélio P. Carvalho

  • Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures : A randomized, double-blind, placebo-controlled, parallel-group phase III study

    Christian Elger;Peter Halász;Joana Maia;Luis Almeida

  • Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives.

    Jan Benes;António Parada;Anabela A. Figueiredo;Paula C. Alves

  • Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial

    Joaquim J Ferreira;Andrew Lees;José-Francisco Rocha;Werner Poewe

  • Catechol-O-methyltransferase and its inhibitors in Parkinson's disease.

    Maria João Bonifácio;P. Nuno Palma;Luís Almeida;Luís Almeida;Patrício Soares-da-Silva;Patrício Soares-da-Silva

  • Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease.

    F Magro;M A Vieira-Coelho;S Fraga;M P Serrão

  • Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells (Journal of Clinical Investigation (2008) 118, (2180-2189) DOI: 10.1172/JCI33637)

    Hewang Li;Ines Armando;Peiying Yu;Crisanto Escano

  • Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.

    E. Ben-Menachem;A.A. Gabbai;A. Hufnagel;J. Maia

  • Eslicarbazepine acetate (BIA 2-093).

    Luis Almeida;Patrício Soares-da-Silva

  • Pharmacokinetics and drug interactions of eslicarbazepine acetate

    Meir Bialer;Patricio Soares-da-Silva;Patricio Soares-da-Silva

  • Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase

    László E. Kiss;Humberto S. Ferreira;Leonel Torrão;Maria João Bonifácio

  • Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.

    A. Gil-Nagel;J. Lopes-Lima;L. Almeida;L. Almeida;J. Maia

  • Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine

    R Pedrosa;P Soares-da-Silva

  • Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive

    Tom R. Hollon;Martin J. Bek;Jean E. Lachowicz;Marjorie A. Ariano

  • Eslicarbazepine Acetate: A Double-blind, Add-on, Placebo-controlled Exploratory Trial in Adult Patients with Partial-onset Seizures

    Christian Elger;Meir Bialer;Joyce A. Cramer;Joana Maia

  • Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial

    Andrew J Lees;Joaquim Ferreira;Olivier Rascol;Werner Poewe

  • Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.

    Michael R. Sperling;Bassel Abou-Khalil;Jay Harvey;Joanne B. Rogin

  • Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine.

    Dominik Hainzl;António Parada;Patrı́cio Soares-da-Silva

  • Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels : Comparison with carbamazepine

    M. J. Bonifácio;R. D. Sheridan;A. Parada;R. A. Cunha

Frequent Co-Authors

Luís Pereira de Almeida
Luís Pereira de Almeida University of Coimbra
Luis Almeida
Luis Almeida University of Porto
Andrew J. Lees
Andrew J. Lees University College London
Pedro A. Jose
Pedro A. Jose George Washington University
Werner Poewe
Werner Poewe Innsbruck Medical University
Maria Helena Fernandes
Maria Helena Fernandes University of Porto
Olivier Rascol
Olivier Rascol Federal University of Toulouse Midi-Pyrénées
Christian E. Elger
Christian E. Elger University Hospital Bonn
Elinor Ben-Menachem
Elinor Ben-Menachem University of Gothenburg
Maria Arménia Carrondo
Maria Arménia Carrondo Universidade Nova de Lisboa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring an education in Biology or Biochemistry opens the door to many rewarding careers and flexible learning options. For those seeking a fast track, an online bachelor's degree in biology can provide a strong foundation and accommodate busy schedules.

If you're interested in healthcare, there are specialized online pathways to consider. For example, current medical assistants can transition smoothly into nursing roles through cma to lpn bridge programs online, improving their career prospects in the process. Those new to the field might look at earning an asn online, opening doors to patient care and clinical roles.

Biology majors with an interest in health and wellness may also consider nutrition careers. Healthcare’s growing emphasis on preventive care means an online dietitian degree can lead to in-demand work in hospitals, community health, or private practice.

These online degrees and bridge programs make it easier than ever to advance your education and launch a meaningful career in science or healthcare.

Best Scientists Citing Patrício Soares-da-Silva

Trending Scientists

Recently Published Articles